-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Letter - Possible deleterious effects of adjunctive omega-3 fatty acids in post-traumatic stress disoder patients
(2106) Views (367) Full article downloads
Authors: Kaplan Zeev, Matar Michael, Kamin Ram, Cohen Hagit
Published Date February 2005
Volume 2005:1(2) Pages 187 - 188
DOI: http://dx.doi.org/10.2147/NDT.S
Kaplan Zeev, Matar Michael, Kamin Ram, Cohen Hagit
Ministry of Health Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Since anger and hostility are frequently pivotal problem behaviors in post-traumatic stress disorder (PTSD) patients and depression is a common comorbid feature of PTSD, we initiated a preliminary open trial of dietary supplementation with capsules of fish oil rich in eicosapentaenoic acid (EPA) in a group of PTSD patients with these problems. Our purpose in the present study was to examine whether EPA-rich fish oil has any effect on the symptoms of PTSD patients, especially those related to depression, anger, and hostility.
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
- Moderate alcohol consumption and cognitive risk
